 | Up a level |
Prince, H. Miles, Hutchings, Martin 
ORCID: 0000-0003-3873-1741, Domingo-Domenech, Eva, Eichenauer, Dennis A. and Advani, Ranjana ORCID: 0000-0002-3219-2292
(2023).
Anti-CD30 antibody-drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives.
Ann. Hematol., 102 (1).
S. 13 - 30.
NEW YORK:
SPRINGER.
ISSN 1432-0584
Boell, Boris, Fossa, Alexander, Goergen, Helen, Kamper, Peter, Leppa, Sirpa, Molin, Daniel, Meissner, Julia, Ritter, Ellen, Christensen, Jacob H., Hutchings, Martin ORCID: 0000-0003-3873-1741, Fuchs, Michael, Engert, Andreas, Kobe, Carsten and Borchmann, Peter
(2018).
B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG).
Blood, 132.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
Broeckelmann, Paul J., Mueller, Horst, Casasnovas, Olivier, Hutchings, Martin ORCID: 0000-0003-3873-1741, von Tresckow, Bastian, Borchmann, Peter, Moskowitz, Craig and Engert, Andreas
(2015).
Risk Factors and a Prognostic Score for Progression Free Survival after Treatment with Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed or Refractory Hodgkin Lymphoma (rrHL).
Blood, 126 (23).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020